C Diff Foundation

Latest from C Diff Foundation

Ibezapolstat Demonstrates 100% C Difficile Cure, No Recurrence in Small Study

November 05, 2021

Video

Results on this investigational antibiotic in its phase 2A study were presented at the C Diff. Conference today.

Conference Coverage: New Challenges and Treatments for C Difficile Infection

November 05, 2021

Article

Presentation highlights from the second and final day of the 9th Annual International C. diff Conference & Health Expo.

An End In Sight for C Difficile?

November 05, 2021

Video

At the C Diff Foundation Conference, promising investigational modalities and therapies, as well as better treatment approaches are all being discussed in hopes of some real inroads being made in this field in the near future.

Is There Still Value in Prescribing Metronidazole for C Difficile Treatment?

November 05, 2021

Video

Although no longer indicated as a first-line therapy, metronidazole still has therapeutic benefits and can serve patients in certain settings and circumstances.

Recurrent Infections and Other Challenges of C difficile Prevention

November 04, 2021

Article

Highlights from some of this afternoon's presenters at the 9th Annual International C diff Conference & Health Expo.

Moving Forward: Investigational C Diff Vaccine, Therapeutics Headline Conference

November 04, 2021

Article

Highlights from the morning session of the C Diff Foundation Conference included data about Pfizer's investigational vaccine, insights about Seres Therapeutics microbiome therapeutic, and a look at CDI incidence rates around COVID-19.